Retension Pharmaceuticals
RTSN
#9486
Rank
HK$1.05 B
Marketcap
HK$126.99
Share price
-0.92%
Change (1 day)
N/A
Change (1 year)

Revenue for Retension Pharmaceuticals (RTSN)

Revenue in 0 (TTM): N/A

.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Retension Pharmaceuticals from to

Annual revenue

Year Revenue Change